An October 2025 HIDA survey revealed that medical manufacturing continues to move out of China and that positive incentives are needed from the U.S. government for more production to be reshored. HIDA periodically surveys medical product manufacturers to identify key factors driving where and how medical products are manufactured.

Download PDF
(Adobe PDF File)

Domestic Manufacturing Expansion


Business Considerations Remain Primary Factors

Economic factors rated impactful on locating manufacturing facility

42%

of manufacturers manufacture the majority of their medical products in the U.S.

67%

of manufacturers expect domestic manufacturing of their healthcare products to increase over the next 5 years.

52%

of manufacturers plan to expand their domestic manufacturing footprint over the next 2 years.

Other Policies Can Support Domestic Manufacturing

Government policies rated “Most Impactful” to manufacturing facility location.

Industry Anticipates Movement Out Of China

Sourcing Of Raw Materials Remains An Issue For U.S. Manufacturers

/am/images/4Q/advocacy/tariffs/tariff-policy-clearinghouse-500x400.jpg

Tariff Policy Clearinghouse

Policy Issue

Navigate key U.S. tariff policies affecting the healthcare supply chain.

Learn More >